U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202344

BINOSTO (ALENDRONATE SODIUM)
EQ 70MG BASE
Marketing Status: Prescription
Active Ingredient: ALENDRONATE SODIUM
Proprietary Name: BINOSTO
Dosage Form; Route of Administration: TABLET, EFFERVESCENT; ORAL
Strength: EQ 70MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N202344
Product Number: 001
Approval Date: Mar 12, 2012
Applicant Holder Full Name: ASCEND THERAPEUTICS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top